Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
4 items
The FDA granted accelerated approval to atacicept (Trutakna) for primary IgA nephropathy, the first therapy to block two key immune signalin...
View — FDA Clears First BAFF/APRIL Blocker for Kidney Disease Linked to Autoimmunity »Health Canada approved Novartis's atrasentan (Vanrafia) to reduce proteinuria in adults with primary IgA nephropathy at risk of rapid diseas...
View — Health Canada Clears New Kidney Drug for IgA Nephropathy »The FDA has approved atacicept (Trutakna), a new antibody-blocking drug for the autoimmune kidney disease IgA nephropathy, after it reduced...
View — FDA Approves Atacicept (Trutakna) for IgA Nephropathy »